Atlas Trials

Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and Adolescents

Clinical trial NCT00352768 · TERMINATED

Trial details

NCT number
NCT00352768
Sponsor
Solvay Pharmaceuticals
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Obsessive Compulsive Disorder
Start date
2006-08-01
Primary completion
2009-04-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.